Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Thiamazole

Treatment failure

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Torres Torres MT, et al. Teprotumumab In Unexplored Presentation Of Thyroid Eye Disease. Journal of the Endocrine Society 7 (Suppl.): A1019 abstr. FRI572, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.1915 [abstract] Torres Torres MT, et al. Teprotumumab In Unexplored Presentation Of Thyroid Eye Disease. Journal of the Endocrine Society 7 (Suppl.): A1019 abstr. FRI572, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.1915 [abstract]
Metadaten
Titel
Thiamazole
Treatment failure
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51273-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Metformin

Case report

Pembrolizumab

Case report

Multiple drugs

Case report

Thiamazole

Case report

Tozinameran